Preventing Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a common problem that affects many patients undergoing chemotherapy. A study published in Supportive Care and Cancer investigated the use of photobiomodulation therapy (laser therapy) for the prevention of CIPN. The study found that treating patients with laser therapy twice a week during their chemotherapy regime resulted in a significant improvement in neuropathy symptoms and functional capacity compared to the control group. The treatment group experienced fewer symptoms such as numbness and discomfort in the hands and feet, and had better endurance as measured by the six-minute walk test. Though more research is needed, these findings highlight the potential benefits of early intervention with laser therapy to prevent CIPN in breast cancer patients.